US Stock MarketDetailed Quotes

HCWB HCW Biologics

Watchlist
  • 0.420
  • +0.002+0.48%
Close Dec 27 16:00 ET
  • 0.412
  • -0.008-1.98%
Post 20:01 ET
18.71MMarket Cap-0.42P/E (TTM)

HCW Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
47.64%-2.93M
48.23%-4.86M
0.94%-3.6M
-116.77%-22.51M
-2.78%-3.89M
-141.46%-5.59M
-249.16%-9.39M
-128.51%-3.64M
5.37%-10.39M
-12.22%-3.79M
Net income from continuing operations
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
Operating gains losses
----
----
----
---15.63K
--0
----
----
----
----
----
Depreciation and amortization
-53.70%128.45K
-54.30%129.93K
-18.52%243.5K
58.14%1.14M
5.13%274.55K
68.84%277.45K
90.09%284.33K
109.30%298.85K
32.06%717.85K
143.02%261.16K
Other non cash items
--0
--0
-300.00%-418
-179.99%-1.67K
-200.00%-626
-200.00%-627
-200.00%-627
0.00%209
-92.61%2.09K
--626
Change In working capital
155.57%614.93K
281.91%10.05M
242.19%3.38M
-286.61%-4.64M
-12.89%1M
-201.72%-1.11M
-1,573.08%-5.52M
899.48%986.71K
70.96%2.49M
252.36%1.15M
-Change in receivables
209.28%3.13K
154.77%248.91K
283.03%631.87K
-292.72%-1.12M
-1,228.74%-825.68K
66.74%-2.87K
-320.54%-454.48K
139.28%164.97K
-112.03%-284.7K
1.37%-62.14K
-Change in prepaid assets
162.25%125.24K
107.32%401.17K
66.02%302.64K
-294.04%-4.82M
8.71%683.42K
-1,994.85%-201.19K
-1,233.74%-5.48M
-86.79%182.29K
188.69%2.48M
201.74%628.67K
-Change in payables and accrued expense
159.33%486.56K
1,801.51%9.4M
247.65%2.5M
287.21%1.62M
97.45%1.23M
-171.64%-820.12K
278.66%494.25K
167.10%718.68K
-77.85%418.21K
951.96%621.19K
-Change in other current liabilities
--0
--0
28.63%-56.54K
-154.78%-326.74K
-114.00%-83.75K
-113.92%-82.5K
-113.84%-81.27K
-531.63%-79.23K
---128.25K
---39.14K
Cash from discontinued investing activities
Operating cash flow
47.64%-2.93M
48.23%-4.86M
0.94%-3.6M
-116.77%-22.51M
-2.78%-3.89M
-141.46%-5.59M
-249.16%-9.39M
-128.51%-3.64M
5.37%-10.39M
-12.22%-3.79M
Investing cash flow
Cash flow from continuing investing activities
-100.40%-37.06K
101.19%18.57K
56.82%-129.71K
-74.18%3.8M
-5,309.54%-3.72M
37.52%9.37M
-11,959.46%-1.56M
-103.77%-300.39K
142.00%14.71M
-187.35%-68.69K
Net PPE purchase and sale
94.12%-37.06K
101.19%18.57K
56.82%-129.71K
39.63%-6.2M
-5,309.54%-3.72M
93.80%-630.05K
-11,959.46%-1.56M
-1,175.30%-300.39K
-21,640.32%-10.28M
-246.00%-68.69K
Net investment purchase and sale
----
----
----
-59.97%10M
--0
----
----
----
171.44%24.98M
--0
Cash from discontinued investing activities
Investing cash flow
-100.40%-37.06K
101.19%18.57K
56.82%-129.71K
-74.18%3.8M
-5,309.54%-3.72M
37.52%9.37M
-11,959.46%-1.56M
-103.77%-300.39K
142.00%14.71M
-187.35%-68.69K
Financing cash flow
Cash flow from continuing financing activities
31,576.24%2.8M
24,807.64%1.92M
222,022.78%4.22M
-100.23%-14.53K
61.73%-15.25K
-100.14%-8.9K
28.53%7.71K
-16.37%1.9K
-87.27%6.27M
-753.00%-39.85K
Net issuance payments of debt
31,281.84%2.8M
--1.92M
--1.72M
-100.59%-38.27K
---29.29K
---8.98K
--0
--0
--6.45M
--0
Net common stock issuance
--0
--0
131,528.62%2.5M
50.46%23.74K
140.82%14.04K
-94.98%84
28.53%7.71K
-16.37%1.9K
-99.97%15.78K
-4.44%5.83K
Net other financing activities
----
----
----
----
----
----
----
----
97.18%-190.55K
---45.68K
Cash from discontinued financing activities
Financing cash flow
31,576.24%2.8M
24,807.64%1.92M
222,022.78%4.22M
-100.23%-14.53K
61.73%-15.25K
-100.14%-8.9K
28.53%7.71K
-16.37%1.9K
-87.27%6.27M
-753.00%-39.85K
Net cash flow
Beginning cash position
-84.41%1.16M
-77.79%4.08M
-83.90%3.6M
90.32%22.33M
-57.21%11.22M
-51.69%7.45M
1.50%18.39M
90.32%22.33M
38.73%11.73M
73.38%26.22M
Current changes in cash
-104.32%-163.09K
73.29%-2.92M
112.42%488.98K
-276.78%-18.73M
-95.64%-7.63M
-65.09%3.77M
-305.70%-10.94M
-161.64%-3.94M
223.55%10.6M
-14.83%-3.9M
End cash Position
-91.10%998.22K
-84.41%1.16M
-77.79%4.08M
-83.90%3.6M
-83.90%3.6M
-57.21%11.22M
-51.69%7.45M
1.50%18.39M
90.32%22.33M
90.32%22.33M
Free cash flow
52.35%-2.96M
55.76%-4.84M
5.21%-3.73M
-38.99%-28.72M
-97.26%-7.61M
50.18%-6.22M
-305.08%-10.95M
-143.77%-3.94M
-87.44%-20.66M
-13.59%-3.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 47.64%-2.93M48.23%-4.86M0.94%-3.6M-116.77%-22.51M-2.78%-3.89M-141.46%-5.59M-249.16%-9.39M-128.51%-3.64M5.37%-10.39M-12.22%-3.79M
Net income from continuing operations 20.98%-3.9M-254.99%-15.28M-47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M
Operating gains losses ---------------15.63K--0--------------------
Depreciation and amortization -53.70%128.45K-54.30%129.93K-18.52%243.5K58.14%1.14M5.13%274.55K68.84%277.45K90.09%284.33K109.30%298.85K32.06%717.85K143.02%261.16K
Other non cash items --0--0-300.00%-418-179.99%-1.67K-200.00%-626-200.00%-627-200.00%-6270.00%209-92.61%2.09K--626
Change In working capital 155.57%614.93K281.91%10.05M242.19%3.38M-286.61%-4.64M-12.89%1M-201.72%-1.11M-1,573.08%-5.52M899.48%986.71K70.96%2.49M252.36%1.15M
-Change in receivables 209.28%3.13K154.77%248.91K283.03%631.87K-292.72%-1.12M-1,228.74%-825.68K66.74%-2.87K-320.54%-454.48K139.28%164.97K-112.03%-284.7K1.37%-62.14K
-Change in prepaid assets 162.25%125.24K107.32%401.17K66.02%302.64K-294.04%-4.82M8.71%683.42K-1,994.85%-201.19K-1,233.74%-5.48M-86.79%182.29K188.69%2.48M201.74%628.67K
-Change in payables and accrued expense 159.33%486.56K1,801.51%9.4M247.65%2.5M287.21%1.62M97.45%1.23M-171.64%-820.12K278.66%494.25K167.10%718.68K-77.85%418.21K951.96%621.19K
-Change in other current liabilities --0--028.63%-56.54K-154.78%-326.74K-114.00%-83.75K-113.92%-82.5K-113.84%-81.27K-531.63%-79.23K---128.25K---39.14K
Cash from discontinued investing activities
Operating cash flow 47.64%-2.93M48.23%-4.86M0.94%-3.6M-116.77%-22.51M-2.78%-3.89M-141.46%-5.59M-249.16%-9.39M-128.51%-3.64M5.37%-10.39M-12.22%-3.79M
Investing cash flow
Cash flow from continuing investing activities -100.40%-37.06K101.19%18.57K56.82%-129.71K-74.18%3.8M-5,309.54%-3.72M37.52%9.37M-11,959.46%-1.56M-103.77%-300.39K142.00%14.71M-187.35%-68.69K
Net PPE purchase and sale 94.12%-37.06K101.19%18.57K56.82%-129.71K39.63%-6.2M-5,309.54%-3.72M93.80%-630.05K-11,959.46%-1.56M-1,175.30%-300.39K-21,640.32%-10.28M-246.00%-68.69K
Net investment purchase and sale -------------59.97%10M--0------------171.44%24.98M--0
Cash from discontinued investing activities
Investing cash flow -100.40%-37.06K101.19%18.57K56.82%-129.71K-74.18%3.8M-5,309.54%-3.72M37.52%9.37M-11,959.46%-1.56M-103.77%-300.39K142.00%14.71M-187.35%-68.69K
Financing cash flow
Cash flow from continuing financing activities 31,576.24%2.8M24,807.64%1.92M222,022.78%4.22M-100.23%-14.53K61.73%-15.25K-100.14%-8.9K28.53%7.71K-16.37%1.9K-87.27%6.27M-753.00%-39.85K
Net issuance payments of debt 31,281.84%2.8M--1.92M--1.72M-100.59%-38.27K---29.29K---8.98K--0--0--6.45M--0
Net common stock issuance --0--0131,528.62%2.5M50.46%23.74K140.82%14.04K-94.98%8428.53%7.71K-16.37%1.9K-99.97%15.78K-4.44%5.83K
Net other financing activities --------------------------------97.18%-190.55K---45.68K
Cash from discontinued financing activities
Financing cash flow 31,576.24%2.8M24,807.64%1.92M222,022.78%4.22M-100.23%-14.53K61.73%-15.25K-100.14%-8.9K28.53%7.71K-16.37%1.9K-87.27%6.27M-753.00%-39.85K
Net cash flow
Beginning cash position -84.41%1.16M-77.79%4.08M-83.90%3.6M90.32%22.33M-57.21%11.22M-51.69%7.45M1.50%18.39M90.32%22.33M38.73%11.73M73.38%26.22M
Current changes in cash -104.32%-163.09K73.29%-2.92M112.42%488.98K-276.78%-18.73M-95.64%-7.63M-65.09%3.77M-305.70%-10.94M-161.64%-3.94M223.55%10.6M-14.83%-3.9M
End cash Position -91.10%998.22K-84.41%1.16M-77.79%4.08M-83.90%3.6M-83.90%3.6M-57.21%11.22M-51.69%7.45M1.50%18.39M90.32%22.33M90.32%22.33M
Free cash flow 52.35%-2.96M55.76%-4.84M5.21%-3.73M-38.99%-28.72M-97.26%-7.61M50.18%-6.22M-305.08%-10.95M-143.77%-3.94M-87.44%-20.66M-13.59%-3.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List